DRH1 – a novel blood-based HPV tumour marker

BACKGROUND: To date, no studies have successfully shown that a highly specific, blood-based tumour marker to detect clinically relevant HPV-induced disease could be used for screening, monitoring therapy response or early detection of recurrence. This study aims to assess the clinical performance of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Weiland, Thomas, Eckert, Alexander, Tomazic, Peter Valentin, Wolf, Axel, Pondorfer, Prisca, Vasicek, Sarah, Graupp, Matthias, Holzmeister, Clemens, Moser, Ulrich, Andrianakis, Alexandros, Kangler, Georg, Kiss, Peter, Brcic, Luka, Kappler, Matthias, Wickenhauser, Claudia, Haak, Anja, Krüger, Maximilian, Al-Nawas, Bilal, Blatt, Sebastian, Brockmeyer, Norbert, Skaletz-Rorowski, Adriane, Potthoff, Anja, French, Lars E., Charnowski, Sara, Reinholz, Markus, Kaufmann, Andreas M., Thies, Sarah, Lambrecht, Hans-Georg, Seliger, Barbara, Wild, Dominik C., Thurnher, Dietmar
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300133/
https://ncbi.nlm.nih.gov/pubmed/32535546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102804
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados